Literature DB >> 21797966

Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients.

V C De Oliveira Almeida, A C De Souza Ferreira, D D Ribeiro, K B Gomes Borges, A P Salles Moura Fernandes, A L Brunialti Godard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21797966     DOI： 10.1111/j.1538-7836.2011.04452.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

1.  Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study.

Authors:  Vanessa Cristina de Oliveira Almeida; Daniel Dias Ribeiro; Karina Braga Gomes; Ana Lúcia Brunialti Godard
Journal:  Mol Diagn Ther       Date:  2014-12       Impact factor: 4.074

2.  Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.

Authors:  Letícia C Tavares; Nubia E Duarte; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo Caleb Junior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2018-07-26       Impact factor: 2.953

Review 3.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

4.  Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.

Authors:  Larisa H Cavallari; Minoli Perera; Mia Wadelius; Panos Deloukas; Gelson Taube; Shitalben R Patel; Keston Aquino-Michaels; Marlos A G Viana; Nancy L Shapiro; Edith A Nutescu
Journal:  Pharmacogenet Genomics       Date:  2012-02       Impact factor: 2.089

5.  Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

Authors:  Marianne Samir Makboul Issac; Maggie S El-Nahid; Marian Youssry Wissa
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

6.  Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients.

Authors:  Letícia C Tavares; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo C J L Santos
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

7.  A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study.

Authors:  Angela Roco; Elena Nieto; Marcelo Suárez; Mario Rojo; Maria Paz Bertoglia; Gabriel Verón; Francisca Tamayo; Annabella Arredondo; Daniela Cruz; Jessica Muñoz; Gabriela Bravo; Patricio Salas; Fanny Mejías; Gerald Godoy; Paulo Véliz; Luis Abel Quiñones
Journal:  Front Pharmacol       Date:  2020-04-06       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.